HedgeChatter

  • Home /
  • Tag Archives

FRX

3:54 am Forest Labs and Gedeon Richter announce positive Phase IIb topline results for Cariprazine for the treatment of bipolar depression

moreView todays social media effects on FRXView the latest stocks trending across Twitter. Click to view dashboardSee who Forest is hiring next, click here to view […]

April 1, 2014 Bystocknews , Comments Off on 3:54 am Forest Labs and Gedeon Richter announce positive Phase IIb topline results for Cariprazine for the treatment of bipolar depression read more

Gedeon Richter Plc. and Forest Laboratories Inc., Announce Positive Phase IIb Topline Results for Cariprazine as Adjunctive Therapy in the Treatment of Major Depressive Disorder

[at noodls] – The trial consisted of three treatment groups, cariprazine 1.0 – 2.0 mg/day + ADT and cariprazine 2.0 – 4.5 mg/day + ADT, and placebo + ADT. The group who received cariprazine 2.0 – 4.5 mg/day + ADT demonstrated … moreView todays social media effects on FRXView the latest stocks trending across Twitter. Click to view dashboardSee who […]

March 21, 2014 Bystocknews , Comments Off on Gedeon Richter Plc. and Forest Laboratories Inc., Announce Positive Phase IIb Topline Results for Cariprazine as Adjunctive Therapy in the Treatment of Major Depressive Disorder read more

Forest Laboratories, Inc. and Gedeon Richter Plc. Announce Positive Phase IIb Topline Results for Cariprazine as Adjunctive Therapy in the Treatment of Major Depressive Disorder

[Business Wire] – Forest Laboratories, Inc. and Gedeon Richter Plc. today announced positive topline results from a Phase IIb trial evaluating the efficacy and safety of the investigation moreView todays social media effects on FRXView the latest stocks trending across Twitter. Click to view dashboardSee who Forest is hiring next, click here to view […]

March 21, 2014 Bystocknews , Comments Off on Forest Laboratories, Inc. and Gedeon Richter Plc. Announce Positive Phase IIb Topline Results for Cariprazine as Adjunctive Therapy in the Treatment of Major Depressive Disorder read more

Forest Laboratories’ Recovery

moreView todays social media effects on FRXView the latest stocks trending across Twitter. Click to view dashboardSee who Forest is hiring next, click here to view […]

March 18, 2014 Bystocknews , Comments Off on Forest Laboratories’ Recovery read more

8:02 am Forest Labs and Adamas Pharmac announce Forest’s submission of New Drug Application for Memantine extended release and Donepezil fixed-dose combination for Alzheimer’s Disease

moreView todays social media effects on FRXView the latest stocks trending across Twitter. Click to view dashboardSee who Forest is hiring next, click here to view […]

March 5, 2014 Bystocknews , Comments Off on 8:02 am Forest Labs and Adamas Pharmac announce Forest’s submission of New Drug Application for Memantine extended release and Donepezil fixed-dose combination for Alzheimer’s Disease read more

Icahn Enterprises reports profit up 144% in 2013

moreView todays social media effects on FRXView the latest stocks trending across Twitter. Click to view dashboardSee who Forest is hiring next, click here to view […]

March 3, 2014 Bystocknews , Comments Off on Icahn Enterprises reports profit up 144% in 2013 read more

Icahn Enterprises reports profit up 144% in 2013

moreView todays social media effects on FRXView the latest stocks trending across Twitter. Click to view dashboardSee who Forest is hiring next, click here to view […]

March 3, 2014 Bystocknews , Comments Off on Icahn Enterprises reports profit up 144% in 2013 read more

Forest Laboratories Submits a New Drug Application for Nebivolol and Valsartan Combination in Hypertension

[at noodls] – NEW YORK–(BUSINESS WIRE)–Forest Laboratories, Inc. (NYSE:FRX) announced that it has submitted a New Drug Application (NDA) to the Food and Drug Administration (FDA) for a fixed dose combination (FDC) … moreView todays social media effects on FRXView the latest stocks trending across Twitter. Click to view dashboardSee who Forest is hiring next, click here to view […]

February 27, 2014 Bystocknews , Comments Off on Forest Laboratories Submits a New Drug Application for Nebivolol and Valsartan Combination in Hypertension read more